LAKESHORE BIOPHARMA CO LTD (LSB) Forecast, Price Target & Analyst Ratings

NASDAQ:LSB • KYG9845F2080

Current stock price

0.627 USD
-0.16 (-20.68%)
At close:
0.5399 USD
-0.09 (-13.89%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LAKESHORE BIOPHARMA CO LTD (LSB).

Forecast Snapshot

Consensus Price Target

Price Target
$31.62
+ 4,943.06% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Dec 15, 2025
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$31.62
Upside
+ 4,943.06%
From current price of $0.63 to mean target of $31.62, Based on 5 analyst forecasts
Low
$31.31
Median
$31.62
High
$32.55

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

5 Wall Street analysts provided a forecast for the next 12 months for LSB. The average price target is 31.62 USD. This implies a price increase of 4943.06% is expected in the next year compared to the current price of 0.627.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

LSB Current Analyst RatingLSB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

LSB Historical Analyst RatingsLSB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 1 2 3 4

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
LSB was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about LSB.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed LSB. So this is just the average opinion of a couple of analysts.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Dec 15, 2025

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2029

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
LSB revenue by date.LSB revenue by date.
687.201M573.418M
-16.56%		614.962M
7.24%		1.403B
128.14%		254.65M
-81.85%		279.9M
9.92%		343.7M
22.79%
EBITDA
YoY % growth
LSB ebitda by date.LSB ebitda by date.
-102.695M
-435.67%		-246.231M
-139.77%		-12.925M
94.75%		115.14M
990.82%		N/AN/AN/A
EBIT
YoY % growth
LSB ebit by date.LSB ebit by date.
-139.382M
-24,789.71%		-288.417M
-106.92%		-49.577M
82.81%		123.13M
348.36%		72.822M
-40.86%		92.534M
27.07%		140.52M
51.86%
Operating Margin
LSB operating margin by date.LSB operating margin by date.
-20.28%-50.30%-8.06%8.78%28.60%33.06%40.88%
EPS
YoY % growth
LSB eps by date.LSB eps by date.
N/AN/AN/A
45.90%		1.02
105.67%		N/AN/AN/A

All data in CNY

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in CNY

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

LSB Yearly Revenue VS EstimatesLSB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 500M 1B
LSB Yearly EPS VS EstimatesLSB Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0 -10 -20 -30

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-29.50%
Revenue Next 5 Year
-19.01%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

LAKESHORE BIOPHARMA CO LTD / LSB Forecast FAQ

What do analysts expect the price target to be for LAKESHORE BIOPHARMA CO LTD (LSB)?

5 analysts have analysed LSB and the average price target is 31.62 USD. This implies a price increase of 4943.06% is expected in the next year compared to the current price of 0.627.

Can you provide the upcoming earnings date for LAKESHORE BIOPHARMA CO LTD?

LAKESHORE BIOPHARMA CO LTD (LSB) will report earnings on 2025-12-15.

Can you provide the expected long term growth rate for LAKESHORE BIOPHARMA CO LTD stock?

The expected long term growth rate for LAKESHORE BIOPHARMA CO LTD (LSB) is -29.5%.